Market Research Logo

IVD in China Market Outlook 2014-2024


Attention: There is an updated edition available for this report.

IVD in China Market Outlook 2014-2024



With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries, and Japan. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets.

Kalorama Information's report, IVD in China Market Outlook 2014-2024, places China and its in vitro diagnostics market in context with the developing world in terms of diseases, economic and healthcare system development, and other key metrics related to healthcare expenditures and diagnostics. China as an in vitro diagnostics market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over the past decade – Brazil, Russia and India; collectively with China referred to as “BRIC” nations. China and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, obesity and diseases of aging.

IVD in China presents current analysis of the Chinese in vitro diagnostics industry and provides forecasts to 2024. The report takes an in-depth look at the IVD market in China, providing data on the size and growth of the total Chinese in vitro diagnostics market as well as on the following IVD market segments:
  • Immunoassays
  • Clinical Chemistry
  • Hematology
  • Point of Care/OTC
  • Molecular
  • Urinalysis
  • Other IVD Tests

Issues & Trends in the IVD Market in China

  • The Future of Chinese Economic Growth
  • Chinese Healthcare Reform and Hospital Infrastructure
  • Market Barriers – Regulation, Policy and Distribution
  • Market Segment Opportunities
  • BRIC Metrics – Chinese IVD Market in Context
  • IVD Spending
  • Strengths – Conditions That Support Market Growth
  • Weaknesses – Factors That Pose Barriers to Market Success and Entry
  • Opportunities – Rural Healthcare and Technology Partnerships
  • Threats – Domestic Competition and Government Policy
IVD in China Market Outlook 2014-2024 provides detailed information regarding the IVD industry and company activity in China. Recent activity of international IVD Companies in China is presented.

International IVD Companies discussed include:

  • Abbott Laboratories
  • Affymetrix, Inc.
  • ALERE
  • Arkray
  • Axis-Shield, plc
  • Beckman Coulter, Inc./Danaher
  • Becton, Dickinson & Co.
  • Biohit Oy
  • bioMérieux, Inc.
  • Bio-RAD Laboratories, Inc.
  • Danaher Corp.
  • Gen-Probe, Inc.
  • Hologic, Inc.
  • Horiba Medical
  • Instrumentation Laboratory
  • IRIS International, Inc.
  • Laboratory Corporation of America
  • Life Technologies Corporation
  • Luminex Corporation
  • MedMira
  • Myriad Genetics
  • Novartis Diagnostics
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Phadia AB
  • Promega Corporation
  • QIAGEN N.V.
  • Radiometer A/S
  • Roche
  • Siemens
  • SuperNova Diagnostics, Inc.
  • Sysmex Corp.
  • Thermo Fisher Scientific

Chinese IVD Companies discussed include:

  • Autobio Group
  • BioSino Bio-Technology and Science, Inc.
  • CapitalBio Corporation
  • Caretium Medical Instruments
  • Chemtron Biotech Co., Ltd.
  • China Health Labs & Diagnostics, Ltd.
  • Daan Gene Co., Ltd.
  • Shanghai Fosun Pharmaceutical Co. Ltd.
  • Hai Kang Life Corporation
  • Shanghai Kehua Bio-engineering
  • Beijing Leadman Biochemistry Co., Ltd.
  • Mindray Medical International, Ltd.

Scope & Methodology

Information for this report was gathered from a wide variety of published sources including company reports, catalogs, materials and public filings; government documents; trade journals; newspapers and business press; analysts’ reports and other sources. Interviews with industry experts were conducted to capture the perspectives from market participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis. Sales estimates are provided for the historic 2009 to 2014 period and forecasts are provided through 2024. The size of each market segment refers to manufacturers’ revenues in U.S. dollars.


  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
    • MAJOR FINDINGS OF THE REPORT
    • CHINA IN CONTEXT –ADEVELOPING ECONOMY WITH DEVELOPED WORLD PROBLEMS
      • Demographic Aging
      • Disease Drivers
      • Infectious Disease Threats
    • CHINESE ECONOMY
    • IVD MARKET IN THE BRIC COUNTRIES
      • Table BRIC IVD Markets by Country, 2014-2019 ($ millions)
    • IVD MARKET IN CHINA
      • Table IVD Sales in China by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2014
    • CHINESE HEALTHCARE REFORM AND HOSPITAL INFRASTRUCTURE
    • MARKET BARRIERS –REGULATION, POLICY AND DISTRIBUTION
      • Regulation and Policy Challenges for International Companies
      • Distribution in China
  • Introduction to Health Care and Diagnostics in the Developing World – China in Context
    • BACKGROUND
    • POPULATION TRENDS AND DISEASE DEMOGRAPHICS
      • Table Elderly Support Ratio in China, Other BRIC and Selected Countries (2010/2050)
      • Table Selected Worldwide Disease Statistics, 2014
    • OBESITY
    • DISEASE TRENDS
      • Diabetes
      • Cancer
      • Allergy and Asthma
      • Cardiovascular Disease
      • Emerging Viruses and Diseases
      • Antimicrobial Drug Resistance
    • CLINICAL LAB TESTS
      • Types of Tests
        • Table Types of IVD and Clinical Laboratory Tests, 2015
      • Venues for Test Usage
    • MARKET SEGMENT OPPORTUNITIES
      • Point-of-Care (POC) Testing
      • Core Lab Tests
        • Table Clinical Lab Counts and Lab Automation Penetration in BRIC Countries
      • Molecular Assays
      • Hematology
      • Coagulation
      • Microbiology
      • Tests Used in Blood Banking
      • Histology and Cytology
    • THE FUTURE OF CHINESE ECONOMIC GROWTH
      • Strong Capital Markets and M&A Activity
      • Rising Standards of Living
      • Corruption and Bribery
    • BRIC METRICS –CHINESE IVDMARKET IN CONTEXT
      • Available Markets – Urban Populations in BRIC Countries
        • Table Available (Urban) Market Development in BRIC Countries (2003- 2014)
      • Paying for Healthcare – Government Expenditures and the Culture of Spending
        • Table Government and Total Health Expenditures in BRIC and Comparison Countries (% of GDP and $ Billions)
      • Healthcare Capacities in BRIC Nations – A Work in Progress
        • Table Growth Rates of Government and Total Healthcare Expenditures and Real GDP (BRIC and Comparison Countries; 2003-2013)
        • Table Healthcare System Capacities – BRIC and Comparison Countries
    • IVD SPENDING
      • Table Per Capita IVD Expenditures and IVD Markets by Country, 2014
      • Table BRIC IVD Markets by Country, 2014-2019 ($ millions)
    • WILL CHINA CAPTURE THE IVD INDUSTRY?
      • Table Selected Made-in-China Lab Supplies
  • China IVD SWOT Analysis
    • INTRODUCTION
    • STRENGTHS –CONDITIONS THAT SUPPORT MARKET GROWTH
      • Government Support of the Emerging Chinese Healthcare Market
      • Western-Style Pharmaceuticals
      • Thriving Biotech Industry
      • Contract Research and High Technology
      • Returning Scientists
      • Growing Hospital Sector
      • Expanding Clinical Labs
    • WEAKNESSES – FACTORS THAT POSE BARRIERS TO MARKET SUCCESS AND ENTRY
      • Traditional Chinese Medicine
      • Resource Constraints in Hospitals
      • Culture and Business Environment
      • Intellectual Property Issues
      • Quality and Safety Concerns
      • Healthcare Insurance
        • Table Out-Of-Pocket, Other Private and Government Healthcare Expenditures in BRIC and Comparison Countries (% of Total Expenditures)
      • Regulation – Product Approval and Clinical Trials
      • Regulation – Healthcare Service Cost Controls
      • Distribution Challenges
    • OPPORTUNITIES –RURAL HEALTHCARE AND TECHNOLOGY PARTNERSHIPS
    • THREATS –DOMESTIC COMPETITION AND GOVERNMENT POLICY
      • Domestic Competition
      • Government Policy and Price Setting
  • China IVD Market Size
    • INTRODUCTION
    • THEMARKET
      • Total Chinese IVD Market
        • Table Total IVD Sales in China, 2014-2024
        • Table IVD Sales in China by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2014 (%)
        • Table IVD Sales in China by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2019 (%)
        • Table IVD Sales in China by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2024 (%)
      • Immunoassays
        • Table Immunoassay Sales in China, 2014-2024
      • Clinical Chemistry
        • Table Clinical Chemistry Sales in China, 2014-2024
      • Hematology
        • Table Hematology Sales in China, 2014-2024
      • Point of Care/OTC
        • Table Point of Care/OTC Sales in China, 2014-2024
      • Molecular
        • Table Molecular Test Sales in China, 2014-2024
      • Urinalysis
        • Table Urinalysis Test Sales in China, 2014-2024
      • Other IVD Tests
        • Table Other IVD Test Sales in China, 2014-2024
  • Industry and Company Activity in China
    • INTRODUCTION
    • MARKET LEADERS IN CHINA
      • Table Leading Global IVD Companies in China
      • Table Leading Domestic IVD Companies in China
      • Table Leading Chinese IVD Companies
    • INTERNATIONAL IVD COMPANIES –RECENT ACTIVITY
      • Abbott Laboratories
      • Affymetrix, Inc.
      • ALERE
      • Arkray
      • Axis-Shield, plc
      • Beckman Coulter, Inc./Danaher
      • Becton, Dickinson & Co.
      • Biohit Oy
      • bioMérieux, Inc.
      • Bio-RAD Laboratories, Inc.
      • Danaher Corp.
      • Gen-Probe, Inc.
      • Hologic, Inc.
      • Horiba Medical
      • Instrumentation Laboratory
      • IRIS International, Inc.
      • Laboratory Corporation of America
      • Life Technologies Corporation
      • Luminex Corporation
      • MedMira
      • Myriad Genetics
      • Novartis Diagnostics
      • Ortho Clinical Diagnostics
      • PerkinElmer
      • Phadia AB
      • Promega Corporation
      • QIAGEN N.V.
      • Radiometer A/S
      • Roche
      • Siemens
      • SuperNova Diagnostics, Inc.
      • Sysmex Corp.
      • Thermo Fisher Scientific
    • CHINESE IVD COMPANIES –RECENT ACTIVITY
      • Autobio Group
      • BioSino Bio-Technology and Science, Inc.
      • CapitalBio Corporation
      • Caretium Medical Instruments
      • Chemtron Biotech Co., Ltd.
      • China Health Labs & Diagnostics, Ltd.
      • Daan Gene Co., Ltd.
      • Shanghai Fosun Pharmaceutical Co. Ltd.
      • Hai Kang Life Corporation
      • Shanghai Kehua Bio-engineering
      • Beijing Leadman Biochemistry Co., Ltd.
      • Mindray Medical International, Ltd.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report